Insider Transactions in Q1 2022 at Viking Therapeutics, Inc. (VKTX)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 15
2022
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
827
-0.35%
|
$3,308
$4.24 P/Share
|
Jan 04
2022
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,432
-1.28%
|
$105,728
$4.62 P/Share
|
Jan 04
2022
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,845
-4.71%
|
$47,380
$4.62 P/Share
|
Jan 04
2022
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,835
-6.09%
|
$35,340
$4.62 P/Share
|
Jan 03
2022
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
173,333
+7.75%
|
-
|
Jan 03
2022
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
36,319
-1.89%
|
$145,276
$4.88 P/Share
|
Jan 03
2022
|
Marianna Mancini Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,333
+23.53%
|
-
|
Jan 03
2022
|
Marianna Mancini Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,919
-2.2%
|
$15,676
$4.88 P/Share
|
Jan 03
2022
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,333
+26.87%
|
-
|
Jan 03
2022
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,097
-3.26%
|
$12,388
$4.88 P/Share
|